Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Should You Buy Mettler-Toledo (MTD) After Golden Cross?
Should You Buy Mettler-Toledo (MTD) After Golden Cross?

Mettler-Toledo International, Inc. (MTD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MTD's 50-day simple moving average broke

Bears are Losing Control Over ESS Tech (GWH), Here's Why It's a 'Buy' Now
Bears are Losing Control Over ESS Tech (GWH), Here's Why It's a 'Buy' Now

A downtrend has been apparent in ESS Tech, Inc. (GWH) lately. While the stock has lost 7.1% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last

How Much Upside is Left in The Pennant Group (PNTG)? Wall Street Analysts Think 31.17%
How Much Upside is Left in The Pennant Group (PNTG)? Wall Street Analysts Think 31.17%

The Pennant Group, Inc. (PNTG) closed the last trading session at $24.7, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?
Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?

West Pharmaceutical Services (WST) closed the last trading session at $246.2, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Elbit Systems Jumps on Record Earnings and a $1.6B Contract
Elbit Systems Jumps on Record Earnings and a $1.6B Contract

A powerful combination of a landmark European contract and a blockbuster earnings report has propelled Elbit Systems (NASDAQ: ESLT) into the spotlight, validating the company's strategy and

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term
Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Here's Why MKS (MKSI) is a Strong Momentum Stock
Here's Why MKS (MKSI) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why Micron (MU) is a Top Momentum Stock for the Long-Term
Why Micron (MU) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Globe Life (GL) is a Strong Momentum Stock
Here's Why Globe Life (GL) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why LATAM (LTM) is a Top Momentum Stock for the Long-Term
Why LATAM (LTM) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Citizens Financial Group (CFG) is a Strong Momentum Stock
Here's Why Citizens Financial Group (CFG) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why Capital One (COF) is a Top Momentum Stock for the Long-Term
Why Capital One (COF) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease

Sanofi SNY announced that the European Medicines Agency (EMA) has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, for treating IgG4-related disease (IgG4-RD).

Copa Holdings' July 2025 Traffic Improves Year Over Year
Copa Holdings' July 2025 Traffic Improves Year Over Year

Copa Holdings CPA, based in Panama City, Panama, is gaining from upbeat passenger volumes. The latest positive update from the Latin American carrier came when it reported robust traffic numbers for

Why T-Mobile (TMUS) is a Top Growth Stock for the Long-Term
Why T-Mobile (TMUS) is a Top Growth Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Qualcomm (QCOM) is a Top Growth Stock for the Long-Term
Why Qualcomm (QCOM) is a Top Growth Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Veracyte (VCYT) is a Strong Growth Stock
Here's Why Veracyte (VCYT) is a Strong Growth Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why FTI Consulting (FCN) is a Top Growth Stock for the Long-Term
Why FTI Consulting (FCN) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates